NPS Intelligence (beta)

Disclosed NPS & retention by vertical

—
Latest disclosed NPS
no score published
0
NPS entries
0 with a number
99%
Retention
13 Mar 2023
2022–23
Years covered
5 entries in all

In their words

“Maintained a greater than 99% developed customer retention rate for OMNI”
— Paul Badawi, Co-Founder and Chief Executive Officer, Sight Sciences · Earnings call, Q4 2022 · 13 Mar 2023
“Developed customer retention rate...was over 99% in Q3”
— Sight Sciences management · Earnings call, Q3 2022 · 13 Nov 2022
“Sight Sciences reports 100% developed customer retention rate in Surgical Glaucoma accounts for Q2 2022.”
— reported by globenewswire.com · 12 Aug 2022

NPS disclosures (0)

Search the database →

No NPS disclosures yet.

Retention disclosures (5)

Open in the retention database →

13 Mar 2023
Retention99%

Retention rate (OMNI): 99% (Q4 2022) — “maintained a greater than 99% developed customer retention rate for OMNI”

— Paul Badawi, Co-Founder and Chief Executive Officer, Sight Sciences · Earnings call, Q4 2022 · 13 Mar 2023
Earnings call, Q4 2022 ↗
13 Nov 2022
Retention99%

Retention rate (OMNI): 99% (Q3 2022) — “developed customer retention rate...was over 99% in Q3”

— Sight Sciences management · Earnings call, Q3 2022 · 13 Nov 2022
Earnings call, Q3 2022 ↗
12 Aug 2022
Retention100%

Sight Sciences reports 100% developed customer retention rate in Surgical Glaucoma accounts for Q2 2022.

— reported by globenewswire.com · 12 Aug 2022
globenewswire.com ↗
11 Aug 2022
Retention100%

Retention rate (Surgical Glaucoma): 100% (Q2 2022) — “Maintained continued excellence in Surgical Glaucoma account retention in the second quarter of 2022 with a developed customer retention rate of 100.0%”

— Sight Sciences · SEC 8-K filing · filed 11 Aug 2022
SEC 8-K filing ↗
10 May 2022
Retention99.7%

Retention rate (Surgical Glaucoma): 99.7% (Q1 2022) — “Demonstrated continued excellence in Surgical Glaucoma account retention in the first quarter of 2022 with a developed customer retention rate of 99.7%”

— Sight Sciences · SEC 8-K filing · filed 10 May 2022
SEC 8-K filing ↗

Lighthouse companies in Pharma, medtech & health distribution

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.